Stockreport

CorMedix Q4 Earnings Call Highlights [Yahoo! Finance]

CorMedix Inc.  (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com
PDF CorMedix (NASDAQ:CRMD) executives said 2025 was a “transformational” year, highlighted by DefenCath reaching peak sales of “just under $260 million,” the acquisition of [Read more]